Livepan-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Pantoprazole 40 mg, indicated for the management of gastroesophageal reflux disease (GERD), dyspepsia, and related upper gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, promoting mucosal healing and symptom relief in acid-related conditions. The synergistic action of these agents provides effective relief from heartburn, acid regurgitation, and gastric discomfort. Livepan-DSR Capsule is typically administered orally, once daily before meals, with dosage adjustments based on clinical response and patient tolerance. It is contraindicated in patients with hypersensitivity to any component, and caution is advised in individuals with hepatic impairment or prolonged QT interval. Common adverse effects may include headache, dry mouth, abdominal cramps, and dizziness. Patients are advised to consult healthcare professionals before use, especially if pregnant, lactating, or on concurrent medications to avoid potential drug interactions. Livepan-DSR Capsule offers a comprehensive therapeutic approach for managing upper gastrointestinal motility and acid secretion abnormalities.